Close

Leerink Positive on Aurinia Pharma (AUPH) Following Presentation of Data from Voclosporin Phase 2b in Lupus Nephritis

Go back to Leerink Positive on Aurinia Pharma (AUPH) Following Presentation of Data from Voclosporin Phase 2b in Lupus Nephritis

Form 6-K Aurinia Pharmaceuticals For: Nov 16

November 16, 2016 8:01 AM EST


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

 REPORT OF FOREIGN PRIVATE... More